Remission in psoriatic arthritis—where are we now?-Reference-Cited by-同舟云学术

Remission in psoriatic arthritis—where are we now?

Published:2017-10-16 Issue:8 Volume:57 Page:1321-1331
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Coates Laura C¹^ORCID,Conaghan Philip G¹,D’Agostino Maria Antonietta²³,De Wit Maarten⁴,FitzGerald Oliver⁵,Kvien Tore K⁶,Lories Rik⁷,Mease Philip⁸⁹,Nash Peter¹⁰,Schett Georg¹¹,Soriano Enrique R¹²,Emery Paul¹

Affiliation:

1. Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK

2. APHP, Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt, France

3. INSERM U1173, Laboratoire d’Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University, Saint-Quentin en Yvelines, France

4. Department of Medical Humanities, VU University Medical Centre, Amsterdam, The Netherlands

5. Department of Rheumatology, St Vincent’s University Hospital, and Conway Institute for Biomolecular Research, University College Dublin, Ireland

6. Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

7. Skeletal Biology and Engineering Research Center, KU Leuven, Leuven, Belgium; Division of Rheumatology, UZ Leuven, Leuven, Belgium

8. University of Washington School of Medicine, Swedish Medical Center, Seattle, WA, USA

9. Clinical Research Division, Swedish Medical Center, Seattle, WA, USA

10. Department of Medicine, University of Queensland, Brisbane, Queensland, Australia

11. Department of Internal Medicine 3 and Institute for Clinical Immunology, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany

12. Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

Funder

National Institute for Health Research Leeds Musculoskeletal Biomedical Research Unit

National Health Service

National Institute for Health Research

Department of Health

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/57/8/1321/25193895/kex344.pdf

Reference83 articles.

1. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis;Coates;Arthritis Rheumatol,2016

2. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update;Gossec;Ann Rheum Dis,2016

3. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force;Smolen;Ann Rheum Dis,2014

4. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics;Gottlieb;J Am Acad Dermatol,2008

5. Treat-to-target as an approach in inflammatory arthritis;Smolen;Curr Opin Rheumatol,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study;Frontiers in Immunology;2023-10-27

3. Treat-to-target in real-life psoriatic arthritis patients: achieving minimal disease activity with bDMARDs/tsDMARDs and potential barriers;Seminars in Arthritis and Rheumatism;2023-10

4. Difficult to treat psoriatic arthritis — how should we manage?;Clinical Rheumatology;2023-04-25

5. Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY;The Lancet Rheumatology;2022-12